切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2023, Vol. 19 ›› Issue (04) : 373 -378. doi: 10.3877/cma.j.issn.1673-5250.2023.04.001

专题论坛

儿童狼疮性肾炎相关肾小管间质损伤的研究现状
娄丽丽, 刘瀚旻()   
  1. 四川大学华西第二医院儿科、出生缺陷与相关妇儿疾病教育部重点实验室、西部妇幼医学研究院血管重构与发育缺陷研究室,成都 610041
  • 收稿日期:2023-03-27 修回日期:2023-07-18 出版日期:2023-08-01
  • 通信作者: 刘瀚旻

Current research status on tubulointerstitial injury in children with lupus nephritis

Lili Lou, Hanmin Liu()   

  1. Department of Pediatrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Vascular Remodeling and Developmental Defects Research Unit of West China Institute of Women and Children′s Health, West China Second University Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China
  • Received:2023-03-27 Revised:2023-07-18 Published:2023-08-01
  • Corresponding author: Hanmin Liu
  • Supported by:
    National Key Research and Development Project(2017YFC0211705)
引用本文:

娄丽丽, 刘瀚旻. 儿童狼疮性肾炎相关肾小管间质损伤的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 373-378.

Lili Lou, Hanmin Liu. Current research status on tubulointerstitial injury in children with lupus nephritis[J/OL]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(04): 373-378.

儿童系统性红斑狼疮(cSLE)临床表现多样,除部分患儿有发热、皮疹等典型表现外,因受累脏器不同,而使临床表现各异,其中肾脏是cSLE患儿最易受累器官,也是导致其死亡的主要原因之一。对cSLE的早期识别、评估疾病活动度、选择合适治疗方案,可有效保护该病患儿的肾功能,改善患儿预后是治疗关键。既往对狼疮性肾炎(LN)患儿多关注肾小球受累情况,而且以肾小球病理损害,作为LN临床分型依据,目前越来越多的研究提示,cSLE相关肾小管间质损伤(TIN),虽然无特异性临床表现,但是对LN患儿的治疗和改善患儿预后有显著影响。笔者拟就LN患儿的临床诊断及发病机制、cSLE TIN的临床意义及TIN的预测指标、LN患儿TIN的临床表现的最新研究现状进行阐述,旨在提高临床对LN患儿cSLE相关TIN的认识,进一步加强对儿童LN患儿的管理。

The clinical manifestations of childhood-onset systemic lupus erythematosus (cSLE) are diverse, except for some typical manifestations of fever and rash, and the clinical manifestations are different due to different organs involved, among which the kidney is the most susceptible organ with cSLE, and also one of the main causes of death. Early identification of cSLE, assessment of disease activity, and selection of appropriate treatment regimens can effectively protect the renal function of children with this disease, and improving the prognosis of children is the key to treatment. In the past, children with lupus nephritis (LN) paid more attention to glomerular involvement, and the pathological damage of the glomerulus was used as the basis for clinical classification of LN, and more and more studies suggest that cSLE-related tubulointerstitial injury (TIN) in children, although there is no specific clinical manifestation, but it has a significant impact on the treatment of children with LN and the improvement of their prognosis. The author intends to elaborate on the clinical diagnosis and pathogenesis of LN children, the clinical significance and predictive indicators of TIN in LN children, and the latest research status of TIN in LN children, aiming to improve clinical understanding of cSLE-related TIN and further strengthen the management of children with LN.

[1]
Harry O, Yasin S, Brunner H. Childhood-onset systemic lupus erythematosus: a review and update[J]. J Pediatr, 2018, 196:22-30.e2. DOI: 10.1016/j.jpeds.2018.01.045.
[2]
Wu CY, Li CF, Wu QJ, et al. Chinese systemic lupus erythematosus treatment and research group registry Ⅸ:clinical features and survival of childhood-onset systemic lupus erythematosus in China[J]. Chin Med J (Engl), 2017, 130(11): 1276-1282. DOI: 10.4103/0366-6999.206346.
[3]
Hiraki LT, Benseler SM, Tyrrell PN, et al. Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study[J]. J Pediatr, 2008, 152(4):550-556. DOI: 10.1016/j.jpeds.2007.09.019.
[4]
中华医学会儿科学分会肾脏学组. 狼疮性肾炎诊治循证指南(2016)[J]. 中华儿科杂志2018, 56(2): 88-94. DOI:10.3760/cma.j.issn.0578-1310.2018.02.003.
[5]
中华医学会风湿病学分会. 系统性红斑狼疮诊治指南(草案)[J]. 中华风湿病学杂志2003, 7(8):508-513.
[6]
Levy DM, Kamphuis S. Systemic lupus erythematosus in children and adolescents [J]. Pediatr Clin North Am, 2012, 59(2): 345-364. DOI: 10.1016/j.pcl.2012.03.007.
[7]
Yu F, Wu LH, Tan Y, et al. Tubulointerstitial lesions of patients with lupus nephritis classified by the 2003 International Society of Nephrology and Renal Pathology Society system [J]. Kidney Int, 2010, 77(9): 820-v9. DOI: 10.1038/ki.2010.13.
[8]
Bajema IM, Wilhelmus S, Alpers CE, et al. Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices [J]. Kidney Int, 2018, 93(4): 789-796. DOI: 10.1016/j.kint.2017.11.023.
[9]
易著文. 儿童常见肾脏疾病诊治循证指南(试行)解读(6):狼疮性肾炎诊断治疗[J]. 中华儿科杂志2010, 48(9):695-697. DOI:10.3760/cma.j.issn.0578-1310.2010.09.015.
[10]
Yin X, Kim K, Suetsugu H, et al. Meta-analysis of 208370 East Asians identifies 113 susceptibility loci for systemic lupus erythematosus[J]. Ann Rheum Dis, 2021, 80(5): 632-640. DOI: 10.1136/annrheumdis-2020-219209.
[11]
Yu C, Li P, Dang X, et al. Lupus nephritis: new progress in diagnosis and treatment[J]. J Autoimmun2022, 132, 102871. DOI:10.1016/j.jaut.2022.102871.
[12]
Obrişcǎ B, Sorohan B, Tuţǎ L, et al. Advances in lupus nephritis pathogenesis: from bench to bedside [J]. Int J Mol Sci, 2021, 22(7): 3766. DOI: 10.3390/ijms22073766.
[13]
Flores-Mendoza G, Sansón SP, Rodríguez-Castro S, et al. Mechanisms of tissue injury in lupus nephritis[J]. Trends Mol Med, 2018, 24(4): 364-378. DOI: 10.1016/j.molmed.2018.02.003.
[14]
Woo JMP, Parks CG, Jacobsen S, et al. The role of environmental exposures and gene-environment interactions in the etiology of systemic lupus erythematous [J]. J Intern Med, 2022, 291(6): 755-778. DOI:10.1111/joim.13448.
[15]
Li R, Meng X, Chen B, et al. Gut Microbiota in Lupus: a butterfly effect? [J]. Curr Rheumatol Rep, 2021, 23(4): 27. DOI: 10.1007/s11926-021-00986-z.
[16]
Truedsson L, Bengtsson AA, Sturfelt G. Complement deficiencies and systemic lupus erythematosus [J]. Autoimmunity, 2007, 40(8): 560-566. DOI: 10.1080/08916930701510673.
[17]
Garcia-Romo GS, Caielli S, Vega B, et al. Netting neutrophils are major inducers of type Ⅰ IFN production in pediatric systemic lupus erythematosus [J]. Sci Transl Med, 2011, 3(73): 73ra20. DOI: 10.1126/scitranslmed.3001201.
[18]
Liu J, Zhang X, Cao X. Dendritic cells in systemic lupus erythematosus: from pathogenesis to therapeutic applications[J]. J Autoimmun, 2022, 132: 102856. DOI:10.1016/j.jaut.2022.102856.
[19]
Nie Y, Zhao L, Zhang X. B cell aberrance in lupus: the ringleader and the solution [J]. Clin Rev Allergy Immunol, 2022, 62(2): 301-323. DOI: 10.1007/s12016-020-08820-7.
[20]
Banchereau R, Hong S, Cantarel B, et al. Personalized immunomonitoring uncovers molecular networks that stratify lupus patients [J]. Cell, 2016, 165(6): 1548-1550. DOI: 10.1016/j.cell.2016.05.057.
[21]
Klavdianou K, Lazarini A, Fanouriakis A. Targeted biologic therapy for systemic lupus erythematosus: emerging pathways and drug pipeline [J]. Bio Drugs, 2020, 34(2): 133-147. DOI: 10.1007/s40259-020-00405-2.
[22]
Shan J, Jin H, Xu Y. T cell metabolism: a new perspective on Th17/Treg Cell imbalance in systemic lupus erythematosus[J]. Front Immunol, 2020, 11: 1027.DOI: 10.3389/fimmu.2020.01027.
[23]
Anders HJ, Saxena R, Zhao MH, et al. Lupus nephritis[J]. Nat Rev Dis Primers, 2020, 6(1): 7. DOI: 10.1038/s41572-019-0141-9.
[24]
Arazi A, Rao DA, Berthier CC, et al. The immune cell landscape in kidneys of patients with lupus nephritis[J]. Nat Immunol, 2019, 20(7): 902-914. DOI:10.1038/s41590-019-0398-x.
[25]
Kramann R, Humphreys BD. Kidney pericytes: roles in regeneration and fibrosis [J]. Semin Nephrol, 2014, 34(4): 374-383. DOI: 10.1016/j.semnephrol.2014.06.004.
[26]
Der E, Suryawanshi H, Morozov P, et al. Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways[J]. Nat Immunol, 2019, 20(7): 915-927. DOI: 10.1038/s41590-019-0386-1.
[27]
Dhingra S, Qureshi R, Abdellatif A, et al. Tubulointerstitial nephritis in systemic lupus erythematosus: innocent bystander or ominous presage [J]. Histol Histopathol, 2014, 29(5): 553-565. DOI: 10.14670/hh-29.10.553.
[28]
Hsieh C, Chang A, Brandt D, et al. Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring [J]. Arthritis Care Res (Hoboken), 2011, 63(6): 865-874. DOI: 10.1002/acr.20441.
[29]
黄雯静,刘倩,王英,等.狼疮肾炎肾小管间质损伤的临床分析[J].实用中西医结合临床2018, 18(12): 7-61;7-9, 61. DOI:10.13638/j.issn.1671-4040.2018.12.003.
[30]
Kozeny GA, Barr W, Bansal VK, et al. Occurrence of renal tubular dysfunction in lupus nephritis [J]. Arch Intern Med, 1987, 147(5): 891-895.
[31]
Howie AJ, Turhan N, Adu D. Powerful morphometric indicator of prognosis in lupus nephritis[J]. QJM, 2003, 96(6): 411-420. DOI: 10.1093/qjmed/hcg074.
[32]
Pagni F, Galimberti S, Galbiati E, et al. Tubulointerstitial lesions in lupus nephritis: international multicentre study in a large cohort of patients with repeat biopsy[J]. Nephrology (Carlton), 2016, 21(1): 35-45. DOI: 10.1111/nep.12555.
[33]
Gomes MF, Mardones C, Xipell M, et al. The extent of tubulointerstitial inflammation is an independent predictor of renal survival in lupus nephritis [J]. J Nephrol, 2021, 34(6): 1897-1905. DOI: 10.1007/s40620-021-01007-z.
[34]
Song J, Yu J, Prayogo GW, et al. Understanding kidney injury molecule 1: a novel immune factor in kidney pathophysiology [J]. Am J Transl Res, 2019, 11(3): 1219-1229.
[35]
Giannico G, Fogo AB. Lupus nephritis: is the kidney biopsy currently necessary in the management of lupus nephritis? [J]. Clin J Am Soc Nephrol, 2013, 8(1): 138-145. DOI: 10.2215/CJN.03400412.
[36]
Humphreys BD, Xu F, Sabbisetti V, et al. Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosis [J]. J Clin Invest, 2013, 123(9): 4023-4035. DOI: 10.1172/jci45361.
[37]
Yi A, Lee CH, Yun YM, et al. Effectiveness of plasma and urine neutrophil gelatinase-associated lipocalin for predicting acute kidney injury in high-risk patients [J]. Ann Lab Med, 2021, 41(1): 60-67. DOI: 10.3343/alm.2021.41.1.60.
[38]
Rubinstein T, Pitashny M, Putterman C. The novel role of neutrophil gelatinase-B associated lipocalin (NGAL)/lipocalin-2 as a biomarker for lupus nephritis [J]. Autoimmun Rev, 2008, 7(3): 229-234. DOI: 10.1016/j.autrev.2007.11.013.
[39]
Satirapoj B, Kitiyakara C, Leelahavanichkul A, et al. Urine neutrophil gelatinase-associated lipocalin to predict renal response after induction therapy in active lupus nephritis [J]. BMC Nephrol, 2017, 18(1): 263. DOI: 10.1186/s12882-017-0678-3.
[40]
Sun F, Teng J, Yu P, et al. Involvement of TWEAK and the NF-κB signaling pathway in lupus nephritis [J]. Exp Ther Med, 2018, 15(3): 2611-2619. DOI: 10.3892/etm.2018.5711.
[41]
Rovin BH, Song H, Birmingham DJ, et al. Urine chemokines as biomarkers of human systemic lupus erythematosus activity[J]. J Am Soc Nephrol, 2005, 16(2): 467-473. DOI: 10.1681/asn.2004080658.
[42]
Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus [J]. Arthritis Rheumatol, 2019, 71(9): 1400-1412. DOI: 10.1002/art.40930.
[43]
Yung S, Tsang RC, Sun Y, et al. Effect of human anti-DNA antibodies on proximal renal tubular epithelial cell cytokine expression: implications on tubulointerstitial inflammation in lupus nephritis [J]. J Am Soc Nephrol, 2005, 16(11): 3281-3294. DOI: 10.1681/asn.2004110917.
[44]
Li SL, Liou LB, Fang JT, et al. Symptomatic renal tubular acidosis (RTA) in patients with systemic lupus erythematosus: an analysis of six cases with new association of type 4 RTA [J]. Rheumatology (Oxford), 2005, 44(9): 1176-1180. DOI: 10.1093/rheumatology/keh705.
[1] 陶宏宇, 叶菁菁, 俞劲, 杨秀珍, 钱晶晶, 徐彬, 徐玮泽, 舒强. 右心声学造影在儿童右向左分流相关疾病中的评估价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 959-965.
[2] 张启龙, 柳亿, 卢会丽, 罗慧, 李成林, 王菁, 王辉. 奥妥珠单抗治疗磷脂酶A2受体相关膜性肾病的疗效与安全性:单中心回顾性分析[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(05): 379-384.
[3] 刘琴, 刘瀚旻, 谢亮. 基质金属蛋白酶在儿童哮喘发生机制中作用的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 564-568.
[4] 向韵, 卢游, 杨凡. 全氟及多氟烷基化合物暴露与儿童肥胖症相关性研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 569-574.
[5] 张洁, 罗小霞, 余鸿. 系统性免疫炎症指数对急性胰腺炎患者并发器官功能损伤的预测价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 68-71.
[6] 刘冉佳, 崔向丽, 周效竹, 曲伟, 朱志军. 儿童肝移植受者健康相关生存质量评价的荟萃分析[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 302-309.
[7] 石海波, 赵旭东, 王聪, 曲巍. 气肿性肾盂肾炎、气肿性膀胱炎并脓毒性休克一例报道并文献复习[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 644-647.
[8] 杨莎莎, 张毛为, 孙宜田, 刘亚南, 位娟, 魏建, 陈碧. 结缔组织疾病相关间质性肺病并发小气道功能障碍临床分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 738-743.
[9] 陆镜明, 韩大为, 任耀星, 黄天笑, 向俊西, 张谞丰, 吕毅, 王傅民. 基于术前影像组学的肝内胆管细胞癌淋巴结转移预测的系统性分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 852-858.
[10] 中华医学会器官移植学分会, 中华医学会外科学分会外科手术学学组, 中华医学会外科学分会移植学组, 华南劈离式肝移植联盟. 劈离式供肝儿童肝移植中国临床操作指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 593-601.
[11] 魏妙艳, 徐近. 合并远处转移胰腺癌系统性治疗的梳理和展望[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 644-650.
[12] 陈意志. 核磁共振钆造影剂导致的肾源性系统性纤维化[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 358-358.
[13] 张琛, 秦鸣, 董娟, 陈玉龙. 超声检查对儿童肠扭转缺血性改变的诊断价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 565-568.
[14] 陈晓胜, 何佳, 刘方, 吴蕊, 杨海涛, 樊晓寒. 直立倾斜试验诱发31 秒心脏停搏的植入心脏起搏器儿童一例并文献复习[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 488-494.
[15] 曹亚丽, 高雨萌, 张英谦, 李博, 杜军保, 金红芳. 儿童坐位不耐受的临床进展[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 510-515.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?